Parents fight as company discontinues drug for 'childhood Alzheimer's'

  • 📰 TODAYshow
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 55%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

Parents say they believe this drug is helping their children; the drug company says research doesn't show a benefit.

in the hopes that another company will take over making the medication that she believes has transformed Marian’s life.Jenna Weets’ son Jeg was diagnosed in 2017. After learning about adrabetadex, she felt hopeful.

Serrano Russi treats Marian and says that the future for children with NPC will be murky after adrabetadex is no longer available.Marian McGlockin, 5, is a "dynamo" who tells knock-knock jokes and plays babysitter with her dolls. When she was first diagnosed with Niemann Pick Type C, she was already losing her ability to speak.remains frustrating. Researchers face challenges because there are fewer people to study, and the condition may progress very differently in different people.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 389. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

日本 最新ニュース, 日本 見出し